Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by qwerty22


T.TH

RE:RE:RE:RE:RE:GH reduces liver fibrosis!

If only they had the cash.....

June 15, 2022

T.TH

RE:RE:RE:RE:GH reduces liver fibrosis!

Abstract?? https://www.newswise.com/pdf_docs/165479878542713_Dichtel...

June 15, 2022

T.TH

RE:Low closing again

???

June 15, 2022

T.TH

ASCO social media coverage

https://www.healio.com/news/hematology-oncology/20220615/lung-breast-bowel...

June 15, 2022

T.TH

RE:RE:10% in 3 days

If they end up borrowing money then I expect the lender cares about sales. ...

June 11, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:FWIW

The Enhurtu "smart bomb" drug data is the absolute best news coming...

June 8, 2022

T.TH

RE:RE:RE:RE:RE:RE:FWIW

My view the hirings are just preparation for success. Doesn't mean it...

June 8, 2022

T.TH

FWIW

I think this article sums up quite nicely a number of different articles I...

June 7, 2022

T.TH

RE:Intercept delays meeting with FDA for Nash

Doesnt seem to be an explanation and the stock is down. Looks like a shift...

June 6, 2022

T.TH

RE:Cancer Trial’s Unexpected Result Remission in Every Patient

This is out of ASCO. Looks like from what I'm reading Enhurtu news is the...

June 6, 2022

T.TH

Oncology news

Some points in here worth our consideration even though it's a different...

June 3, 2022

T.TH

RE:RE:RE:RE:PR points to more detailed strategy

Three green days, the woman doesn't know red! Lee430 wrote: Off to a...

June 2, 2022

T.TH

RE:RE:RE:MTL cancer drug developer Repare US$1-billion-plus deal

Before today they had a market cap of about $380 mil with $300 mil in the...

June 2, 2022

T.TH

RE:RE:RE:RE:PR points to more detailed strategy

give her a pay rise! Lee430 wrote: Off to a good start, up 5.65% south of...

May 31, 2022

T.TH

RE:PR points to more detailed strategy

Curious Paul leads with "strong commercial portfolio" rather than...

May 31, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:No longer accepting…

For me it's about Paul's Rare Disease marketing and whether he is...

May 30, 2022

T.TH

RE:RE:RE:RE:RE:RE:RE:No longer accepting…

scarlet1967 wrote: I do agree i also believe there is good potential for a...

May 30, 2022

T.TH

RE:RE:RE:No longer accepting…

Seems to me like a fairly technical post. There's a vast amount of...

May 30, 2022

T.TH

RE:TH1902 in Melanoma - what to shoot for

Even though the analysts liked this data the market hated it. Stock is down...

May 27, 2022

T.TH

RE:RE:TH1902 in Melanoma - what to shoot for

All right scrap some of my numbers. I had it in my head the group size had...

May 27, 2022

Featured Company